capecitabine has been researched along with Pancytopenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iland, HJ; Mohamed, M; Sharma, S; Supple, SG | 1 |
| Albízuri-Prado, MF; Arranz Sánchez, D; Gómez-Fernández, C; Herranz Pinto, P; Sánchez-Orta, A | 1 |
2 other study(ies) available for capecitabine and Pancytopenia
| Article | Year |
|---|---|
Atypical presentation of therapy-related acute promyelocytic leukaemia with marrow fibrosis.
Topics: Acute Disease; Adenocarcinoma; Antineoplastic Agents; Capecitabine; Chemoradiotherapy; Colorectal Neoplasms; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Middle Aged; Neoplasms, Second Primary; Organoplatinum Compounds; Oxaliplatin; Pancytopenia; Primary Myelofibrosis; Remission Induction; Tretinoin | 2016 |
A fatal drug interaction.
Topics: Antimetabolites, Antineoplastic; Antiviral Agents; Bromodeoxyuridine; Capecitabine; Drug Interactions; Fatal Outcome; Humans; Male; Middle Aged; Pancytopenia | 2017 |